The intestinal epithelium is maintained by intestinal stem cells (ISCs), which produce post-mitotic absorptive and secretory epithelial cells. Initial fate specification toward enteroendocrine, goblet, and Paneth cell lineages is dependent on Atoh1, a master regulator of secretory differentiation. However, the origin of tuft cells, which participate in Type II immune responses to parasitic infection, is less clear and appears to occur in an Atoh1-independent manner. Here we examine the role of Sox4 in ISC proliferation and differentiation.
Introduction
The intestinal epithelium is essential for both digestive and barrier function and contains a diverse complement of post-mitotic cells which carry out complex physiological functions critical for homeostasis. Functional cell types in the intestine can be broadly subdivided into: (a) absorptive enterocytes and (b) secretory lineages, which include antimicrobial-producing Paneth cells, mucus-producing goblet cells, and hormone-secreting enteroendocrine cells (EECs) 1 . Tuft cells, which represent a less wellcharacterized lineage, initiate immune responses to parasitic infections in the intestine [2] [3] [4] [5] .With the exception of long-lived Paneth cells, these post-mitotic lineages are subject to the rapid (5-7 day) and continuous turnover of the intestinal epithelium. Therefore, their numbers must be maintained through constant proliferation and differentiation of the intestinal stem cells (ISCs), which reside in a specialized stem cell niche at the base of the intestinal crypts.
Extrinsic signals from the niche induce regulatory programs in ISCs and their immediate progeny, transit-amplifying progenitor cells (TAs), to drive commitment to different cellular lineages. For example, loss of Notch signaling in ISCs and early progenitors is associated with the induction of secretory differentiation through the derepression of Atoh1, which is widely regarded as the master regulator of secretory fate 6, 7 . Certain pathological settings can shift lineage allocation in the intestine, as exemplified by goblet and tuft cell hyperplasia in the setting of type II immune responses. While tuft cells are also derived from ISCs, the transcriptional regulatory mechanisms governing their differentiation and hyperplastic response to infection remain less well characterized 3 . This is due in part to evidence that tuft cells differentiate independently of Atoh1, but still appear to require downregulation of Notch 6, 8, 9 . Recent studies have demonstrated upregulation of tuft cell numbers following Atoh1 deletion in vivo, and systems biology approaches have supported an Atoh1-independent differentiation program for this lineage 10 . Together, these data suggest an apparently paradoxical Notchrepressed, Atoh1-independepent mechanism for tuft cell specification.
Sry-box containing (Sox) factors are transcription factors with broad regulatory roles in stem cell maintenance and differentiation in many adult tissues, including the intestinal epithelium 11, 12 . Sox9 is known to contribute to Paneth cell differentiation, and previous work from our group has demonstrated that distinct expression levels of Sox9 mark stem and progenitor cell populations from intestinal crypts, including labelretaining cells (LRCs) [13] [14] [15] [16] . The role of other Sox factors in ISC function and differentiation remain uncharacterized.
Sox4 has been associated with the ISC genomic signature and is correlated with increased invasion/metastasis and decreased survival in colon cancer, but its role in intestinal epithelial homeostasis is unknown 17, 18 . In the hematopoietic system, as well as the developing nervous system, pancreas, kidney, and heart, Sox4 is required for both proper cell lineage allocation and maintenance of progenitor pools [19] [20] [21] . The diverse regulatory potential of Sox4, coupled with its known role in a broad range of tissuespecific progenitor populations, led us to hypothesize that it may function as a regulator of ISC maintenance and differentiation. In this study we establish a role for Sox4 in ISC homeostasis and regulation of tuft cell hyperplasia during parasitic helminth infection, which represents a novel pathway for tuft cell specification with important implications for human responses to parasitic disease.
Results

SOX4 is expressed at distinct levels in the ISC zone
To characterize Sox4 expression, we first used in situ hybridization to detect Sox4 mRNA. Consistent with previous reports, Sox4 is restricted to the base of the intestinal crypts in the stem cell zone ( Figure 1A ) 18 Figure 1B ) 23, 24 . Next, we examined SOX4 protein expression by immunofluorescence. SOX4 protein was expressed in a more restricted pattern relative to mRNA. Like Sox9, we observed distinct expression levels of SOX4, which we characterized as "low" and "high" ( Figure 1C ). SOX4 low cells were associated with the crypt base columnar (CBC), active ISC population, in cell positions +1-3 counting from the base of the crypt ( Figure  1C, D) . Interestingly, SOX4
high cells were predominantly found in the supra-Paneth cell position, which is commonly associated with early secretory progenitors, at cell positions +4-7 ( Figure 1C , D) 25 . Unlike SOX9, which is expressed in villus-based EECs/tuft cells, we did not detect any Sox4 mRNA or protein outside of the crypts 13 . Since Sox9 high cells are known to represent EEC-like secretory progenitors, we asked if the SOX4 high population overlapped with Sox9 high cells. However, we found no co-localization between high levels of SOX4 protein and high levels of Sox9 mRNA, as determined by Sox9 EGFP , which is an accurate surrogate of endogenous Sox9 mRNA and protein expression (n = 3 mice, 100 SOX4+ cells per mouse) ( Figure 1E , E') 13, 26 .
Sox9
high -expressing cells are consistent with a subset of label-retaining reserve ISCs (LRCs) located in the supra-Paneth cell position. However, not all LRCs are Sox9 high 23 . We reasoned that the supra-Paneth cell location of SOX4 high cells suggests that they may represent the non-Sox9 high subset of LRCs. To examine this, we counted the number of SOX4 high cells co-localizing with LRCs, as determined by 28 days of continuous labeling with 5-ethynyl-2-deoxyuridine (EdU), followed by 10 days of washout 23, 25 . Surprisingly, we found that no SOX4 high cells were LRCs (n = 3 mice, 100 SOX4+ cells per mouse) ( Figure 1F ). We observed rare co-localization between DCKL1, a tuft cell/reserve ISC biomarker also associated with the +4 position, and SOX4 (5.0% ± 3.0%; Figure 1G ). Finally, we addressed the possibility that SOX4 high cells may represent a quiescent population by co-staining with KI67, which marks all proliferating cells. 90.6 ± 3.2% of SOX4 high cells were found to be proliferative ( Figure 1H ). Together, these data suggest that SOX4 high cells represent ISCs or progenitors, and are distinct from LRC Sox9 high secretory precursors. Co-localization with DCLK1 suggests that a subset of SOX4 high cells may represent tuft cell or non-LRC secretory precursors.
Loss of Sox4 results in increased proliferation and decreased ISC function
Complete deletion of Sox4 results in embryonic lethality 27 . To enable examination of Sox4 function in adult intestinal epithelium, we crossed previously generated Sox4 fl/fl mice to mice expressing Cre recombinase driven by the villin promoter (vilCre), which is constitutively expressed in the intestinal epithelium beginning at E13.5 28, 29 . To examine Sox4 expression, we isolated CD44-and CD44+ populations from control and Sox4cKO adult intestinal epithelium (CD326+) by FACS and confirmed CD44 enrichment by qPCR (Supplementary Figure 1A-C) . CD44 marks crypt cells as well as EECs in the villi (Supplementary Figure 1A) . As expected, control animals exhibited significant enrichment of Sox4 in the CD44+ population, consistent with restricted expression of Sox4 in the intestinal crypts ( Supplementary Figure 2A) . Sox4cKO animals did not express detectable levels of Sox4 mRNA or protein ( Supplementary Figure 2A, B) .
To assay the role of Sox4 in ISC/TA proliferation, we examined KI67 and EdU incorporation, which was administered as a single, 2hr pulse. Sox4cKO crypts exhibited significantly higher percentages of total proliferating cells as well as cells in S-phase (Figure 2A, B) . This increase in proliferation was reflected by increased crypt length in Sox4cKO intestines (Supplementary Figure 2C) . In organoid cultures, Sox4cKO crypts grew at the same rate as control crypts, suggesting that hyperproliferation in the absence of Sox4 may be masked by exogenous growth factors required for organoid culture ( Figure 2C ).
Due to its known role in maintenance of stem/progenitor pools in other tissues, we sought to determine if Sox4 regulates the size or function of the ISC pool. OLFM4, which is an established marker of ISCs, was detected by immunofluorescence to assess ISC numbers, which were unchanged between control and Sox4cKO intestines ( Figure 2D ) 30 . Next, we FACS-isolated CD44-and CD44+ cells from control and Sox4cKO mice and conducted single cell organoid forming assays to test ISC function 31 . As expected, CD44-cells failed to form organoids regardless of Sox4 status ( Figure 2E ). CD44+ cells from Sox4cKO mice produced approximately 50% fewer organoids than controls, demonstrating a significant loss of stemness ( Figure 2E ).
To determine if this functional deficit was coincident with an increase in apoptosis in Sox4cKO samples, we examined cleaved-caspase-3 expression in the crypts of control and Sox4cKO intestines, as well as the number of apoptotic cells in CD44-and CD44+ populations of cells prepared for FACS. In both cases, we found no significant difference in apoptosis between control and Sox4cKO samples (Supplementary Figure  3A , B). However, CD44+ cells from Sox4cKO mice expressed significantly lower levels of Lgr5, consistent with decreased stem cell function ( Figure 2F ). Together, these data indicate that Sox4 does not regulate ISC numbers or apoptosis, but is required for normal ISC function and Lgr5 expression in the intestinal crypt.
Sox4 regulates secretory lineage allocation
We next sought to determine if Sox4 regulates differentiation and intestinal lineage allocation. Goblet cells, detected by expression of MUC2, were found at similar numbers between Sox4cKO and control intestines ( Figure 3A ). CHGA + EECs were found in significantly reduced numbers in the villi of Sox4cKO mice ( Figure 3B ).
Numbers of DCLK1
+ tuft cells were significantly reduced in crypt and villus compartments of Sox4cKO intestines ( Figure 3C ). Paneth cells were increased in Sox4cKO intestines ( Figure 3D ), reflecting additional Paneth cells at higher positions in Sox4cKO crypts (Supplementary Figure 4) . Staining patterns for sucrose isomaltase (SIS), a brush-border enzyme associated with absorptive enterocytes, were unchanged between control and Sox4cKO samples (Supplementary Figure 5A) . Additionally, villus height was unchanged, and no change was observed for Hes1, which specifies absorptive enterocyte fate (Supplementary Figure 2C and Supplementary Figure 5B) .
In order to examine gene regulatory changes in Sox4cKO samples in an unbiased manner, we subjected FACS isolated CD44 -and CD44 + populations to RNA-seq. Consistent with histological observations, decreased expression of genes associated with EEC subpopulations, including pro-EEC transcription factors Isl1, Nkx2.2, and Pax6, was the predominant change observed in Sox4cKO CD44 + populations (Supplementary Figure 1D and Supplementary Table 1) 32, 33 . There were no significant gene expression changes in the CD44 -populations consistent with the restricted expression pattern of SOX4 in CD44 + intestinal crypts and CD44+ status of EECs (Supplementary Figure 1D) . Since the EEC lineage is comprised of a diverse complement of subpopulations, we reexamined Sox4cKO intestines for the presence of hormones produced by specific EEC subtypes. Compared to the modest reduction in CHGA + cell numbers, we found substantial and significant decreases in EEC subpopulations expressing GIP, CCK, SST, GCG, PYY, and GLP-2 ( Figure 3E ). Interestingly, numbers of 5-HT and SUBPexpressing populations remained unchanged ( Figure 3E ).
Since Notch repression is required for EEC specification, we asked if Sox4 is activated following downregulation of Notch. To do so, we treated wild type organoids with the gamma secretase inhibitor DAPT. Since Sox4 has been reported to be regulated by Wnt in colon cancer cell lines and inhibited by Bmp in hair follicle progenitors, we also treated organoids with WNT3A and Noggin, a Bmp antagonist 34, 35 . While Sox4 levels and cell numbers did not respond to Wnt activation or Bmp inhibition, we found that Notch inhibition drove a 2-fold increase in Sox4 expression that coincided with decreased expression of Ascl2, and ISC marker, and increased expression of Ngn3, and early EEC transcription factor (Supplementary Figure 6) . Together, these data demonstrate that Sox4 is required for proper secretory lineage allocation. Furthermore, Sox4 is upregulated following Notch inhibition, consistent with early secretory differentiation responses, and required for proper specification of EEC subpopulations.
Sox4 contributes to tuft cell differentiation and hyperplasia
Since a subset of SOX4 high cells were found to co-localize with DCLK1 and DCLK1 + tuft cells were decreased in Sox4cKO intestines, we sought to examine the regulatory role of Sox4 in tuft cell differentiation more closely. IL-13 is known to induce tuft cell differentiation, and is produced by Group 2 innate lymphoid cells (ILC2) that are recruited to the intestinal epithelium in response to tuft cell secreted IL-25. This mechanism produces an extrinsic feed-forward loop that signals through unknown intrinsic response elements in ISCs and progenitors to drive tuft cell hyperplasia following parasitic helminth infection 2, 5 . We treated wild type intestinal organoids with IL-13 to determine its effect on Sox4. As previously reported, IL-13 induced expression of tuft cell-specific Dclk1 (Supplementary Figure 7A) . Compellingly, IL-13 also induced a dose-dependent upregulation of Sox4, driving an approximately 3-fold increase at the optimal dose (Supplementary Figure 7A) . Levels of Sox4 upregulation correlated closely with Dclk1 induction. As expected, goblet cell Muc2 was the only non-tuft lineage specific gene also upregulated in response to IL-13 (Supplementary Figure 7B) 2 . To determine if Sox4 is required for proper Dclk1 upregulation in response to IL-13, we next treated Sox4cKO and control organoids with IL-13. While control organoids exhibited robust induction of Dclk1 and the tuft cell transcription factor Pou2f3, Sox4cKO organoids failed to significantly upregulate these genes ( Figure 4A) .
Next, we asked if Sox4-driven tuft cell responses were physiologically necessary for clearance of helminth infection. Sox4cKO and control animals were infected with N. brasiliensis, a helminth known to induce tuft cell-mediated type II immune reactions 2, 4, 5 . Intestines were examined 7 days post-infection (d.p.i.), at the peak of tuft cell hyperplasia, when most worms are typically cleared from wild type mice 5 . We first examined SOX4 + cells in control mice. Helminth infection drove a 4-fold increase in the number of SOX4 + cells per crypt ( Figure 4B ). As expected, DCLK1 + cell numbers were largely upregulated in control animals ( Figure 4C ). In contrast, Sox4cKO intestines exhibited an attenuated increase in tuft cell numbers ( Figure 4C ). To determine if impaired tuft cell hyperplasia in Sox4cKO animals affected worm burden at 7d.p.i., we quantified the number of adult worms present in the intestines of infected animals. In order to match worm clearance data with tuft cell hyperplasia in the same mouse, duodenal and ileal tissues were harvested to establish worm counts and jejunal tissues were used for histological studies, discussed above. Control animals exhibited a neartotal clearance of adult worms, while Sox4cKO animals bore a significantly higher worm burden at 7d.p.i. (Figure 4D ). These data implicate Sox4 as a regulator of tuft cell differentiation at physiological baseline, with an important role in tuft cell hyperplasia during helminth infection.
Sox4-and Atoh1-expressing cells form overlapping and distinct populations
Early tuft cell specification remains a paradox in intestinal epithelial differentiation. Atoh1 is accepted as the master regulator of early secretory fate in the intestine, and is de-repressed following loss of Notch signaling 36 . While tuft cells fail to differentiate properly in the presence of constitutively active Notch, multiple lines of evidence demonstrate that a majority of tuft cells are not derived from Atoh1-expressing progenitors 3, 6 . These data suggest the existence of Notch-repressed, Atoh1-independent tuft cell regulatory pathways that remain uncharacterized. Since our data demonstrate that Sox4 is upregulated following Notch inhibition and is involved in tuft cell differentiation, we hypothesized that it might be expressed in an Atoh1-independent manner. We examined SOX4 expression in Atoh1 GFP intestines, and found that 55.3 ± 6.1% of SOX4 high cells were Atoh1-negative, with the remainder co-localizing with Atoh1-GFP ( Figure 5A ).
To examine Sox4 and Atoh1 populations more thoroughly, we reanalyzed previously published single cell RNA-seq (scRNA-seq) data from primary mouse intestinal epithelial cells 37 . Cells were visualized by tSNE dimensionality reduction and classified into previously characterized phenotypic populations ( Figure 5B ) 37 . Next, we queried the distribution of cell types within each of three populations of interest: (1) Sox4+:Atoh1-(n = 617 cells), (2) Sox4+:Atoh1+ (n = 88 cells), and (3) Sox4-:Atoh1+ (n = 162 cell). Within the Sox4+ population, 12.5% of cells were also Atoh1+. Next, we determined the cellular composition of each of our populations of interest. The Sox4+:Atoh1-population consisted primarily of ISCs and progenitor cells (88%), but also contained the highest proportion of tuft cells relative to other populations ( Figure 5C ). The Sox4+:Atoh1+ population was a mix of ISCs and secretory cell types, and contained the highest proportion of EECs relative to other populations ( Figure 5C ). As expected, the Sox4-:Atoh1+ population was comprised mostly of secretory cells, with the lowest proportion of ISCs an progenitor cells and the highest proportion of goblet and Paneth cells relative to other populations ( Figure 5C ). These data demonstrate that Sox4 and Atoh1 form distinct and overlapping populations, and that Sox4 is most strongly correlated with ISCs, progenitors, and tuft cells when expressed exclusively of Atoh1 and more strongly correlated with EECs when co-expressed with Atoh1.
Sox4 drives tuft cell differentiation independently of Atoh1
We next sought to determine if Sox4 is sufficient to drive secretory EEC and tuft cell differentiation. To this end, we generated stable transgenic organoids carrying a cumate-inducible Sox4 overexpression vector (Sox4OE). Gain of function was validated by immunofluorescent detection of SOX4 in empty vector control and induced Sox4OE organoids (Supplementary Figure 8) . To validate organoid models for assessment of Sox4-dependent differentiation phenotypes, we included organoids isolated from Sox4cKO mice in our analyses. As expected, Sox4cKO organoids exhibited very low numbers of DCLK1+ tuft cells and CHGA+ EECs (Figure 6A, B) . In contrast, overexpression of Sox4 resulted in a significant increase in numbers of both tuft cells and EECs, relative to empty vector controls (Fig 6A, B) .
Since scRNA-seq demonstrated differential distribution of Sox4 and Atoh1 across progenitors and secretory cell types, we hypothesized that Sox4 may function independently of Atoh1 in secretory differentiation. To test this, we generated Sox4OE organoids derived from Atoh1 fl/fl :vilCre ER mice. Atoh1 recombination was induced by treating organoids with 1uM 4-OHT once a day for three days and collecting for analysis 24hr following final treatment with 4-OHT. Analysis of Atoh1 expression confirmed the effectiveness of this strategy in generating Atoh1iKO organoids ( Figure 6C ). To assess whether residual ATOH1 protein was exerting continued effects in Atoh1iKO organoids, we next analyzed Muc2 expression, which is associated with Atoh1-dependent goblet cell differentiation. We found that Muc2 levels were also significantly downregulated in Atoh1iKO organoids, suggesting no residual ATOH1 function at the time of organoid analysis ( Figure 6D) .
Next, we examined the effect of Atoh1 and Sox4 on tuft and EEC differentiation. Surprisingly, Dclk1 was significantly downregulated following loss of Atoh1, in direct conflict with reported in vivo data demonstrating an increase in tuft cells in Atoh1-null intestines ( Figure 6E ) 10 . However, treatment of Atoh1iKO organoid cultures with IL13 restored Dclk1 expression to control levels, in contrast to the loss of IL13 responsiveness in Sox4cKO organoids (Supplementary Figure 9) . Overexpression of Sox4 was also sufficient to restore Dclk1 expression levels in the absence of Atoh1 ( Figure 6E ). Unexpectedly, Chga expression levels remained unchanged following loss of Atoh1, and were upregulated by Sox4 in Atoh1iKO organoids ( Figure 6F) . Notably, Sox4OE failed to rescue or upregulate Muc2 expression levels, suggesting specificity to tuft and EEC lineages ( Figure 6D ). To refine these observations, we conducted whole mount staining on Atoh1iKO and Sox4OE organoids and directly quantified tuft and EEC numbers in whole organoids. Quantification by immunofluorescence recapitulated gene expression results, demonstrating upregulation of DCLK1+ tuft cells and CHGA+ EECs in Sox4OE organoids regardless of Atoh1 expression ( Figure 6G and H) . Together, these data demonstrate that Sox4 is sufficient to drive an increase in tuft and EEC differentiation and can do so independently of Atoh1.
Discussion
Here we show that genetic ablation of Sox4 in the intestinal epithelium results in increased numbers of proliferating cells and Paneth cells, as well as a reduction in EEC and tuft cell lineages. Our study supports Sox4 mediated regulation of stem cells in other organ systems by demonstrating that Sox4 regulates ISC function and differentiation toward EECs and tuft cells in the intestinal epithelium. Additionally, we demonstrate that Sox4 has an essential role in pushing lineage allocation toward tuft cell differentiation in response to helminth infection, implying an important role for Sox4 in host responses to pathogens.
Our group and others have reported Sox4 expression in Lgr5+ CBCs, but a role for Sox4 in ISCs has yet to be established 18, 22 . We demonstrate that the numbers of ISCs quantified by OLFM4 immunostaining are unchanged between Sox4cKO and control samples. These data suggest that the associated increase in proliferating cells in Sox4cKO crypts is likely due to increased progenitor numbers and not more robust ISC activity. Rather, in vitro assay of ISC function demonstrated impaired organoid-forming efficiency of single ISCs isolated from Sox4cKO mice. As this dysfunction is not associated with a change in the number of apoptotic cells between control and Sox4cKO mice, it is likely that decreased organoid-forming efficiency is caused by loss of stemness and premature differentiation in Sox4 deficient ISCs. In this regard, Sox4cKO mice demonstrate reduced Lgr5 mRNA. Lgr5 is highly expressed in ISCs and serves as a receptor for R-Spondin ligands that potentiate Wnt-signaling, which is in turn required to maintain stemness 38 . These data indicate that Sox4 is not required for maintaining ISC numbers, but suggests that Sox4 plays a role in maintaining stemness by positively regulating Lgr5 levels. Functionally, this role would be consistent with Sox4 knockout phenotypes in other tissues, including the developing heart, skeletal muscle, nervous, renal, and hematopoietic systems, which often exhibit precocious differentiation and reduced progenitor and post-mitotic cell numbers 19, 20, 27, [39] [40] [41] . Sox4cKO intestines also demonstrate decreased EEC and tuft cell numbers, implying that Sox4 plays a key role in the specification of these secretory lineages. RNAseq analysis demonstrates that Sox4 regulates the expression of the EEC transcription factors, including Isl1, Pax6, and Nkx2-2. Isl1 deletion in the intestine is known to lead to loss of EECs subtypes expressing GIP, CCK, SST, GCG, PYY, and GLP-2 33 . We demonstrate that loss of Sox4 results in a marked reduction of Isl1 expression with a concomitant reduction in the numbers of the same EEC subtypes. Together, these results indicate that Sox4 likely functions upstream of EEC transcription factors Isl1, Pax6, and Nkx2-2 to drive EEC specification.
The mechanisms that give rise to the tuft cell lineage are largely understudied due to the relatively new characterization of tuft cells as a distinct lineage. The role of intestinal tuft cells was recently described by a handful of independent studies, all of which demonstrated tuft cell hyperplasia following infection with parasitic helminths. Pou2f3 is known to be essential for tuft cell differentiation, but is also expressed by mature, villus-based tuft cells 2 . Other transcription factors involved in tuft cell specification and hyperplasia remain unknown, and tuft cell progenitors have no distinct biomarkers 2 . Though SOX4 high cells are relatively rare in homeostasis, we observed a striking increase in SOX4 high cell numbers coincident with peak tuft cell hyperplasia following parasitic infection, suggesting that SOX4 high cells may represent a tuft progenitor population. We show that Sox4cKO epithelium demonstrates attenuated tuft cell hyperplasia, both in response to recombinant IL-13 in vitro and helminth infection in vivo, and that Sox4cKO mice are functionally impaired at clearing worms by 7d.p.i. Notably, IL13-mediated activation of Pou2f3 is also impaired in Sox4cKO organoids, suggesting that Sox4 acts upstream of this established tuft cell transcription factor. Since there is no reporter mouse model for Sox4, we leveraged existing scRNA-seq data to further interrogate the identity of Sox4+ cells. In agreement with histological data, we find that Sox4 is enriched in ISC, progenitor, and secretory populations. Classifying Sox4+ cells by Atoh1 expression reveals a strong correlation between Sox4+:Atoh1-cells and tuft cells and between Sox4+:Atoh1+ cells and EECs, supporting dual roles for Sox4 in tuft and EEC differentiation. Functionally, this role is demonstrated by the ability of ectopic Sox4 expression to induce increased tuft and EEC numbers in organoids.
Lineage specification of tuft cells from the ISC/progenitor pool remains a significant question in the field, as tuft cells are capable of being produced independently of Atoh1, but are inhibited by constitutive Notch signaling 3, 6 . Further, it was recently shown that inducible knockout of Atoh1 in vivo leads to increased tuft cell numbers, implying that Atoh1 may suppress tuft cell differentiation 10 . Surprisingly, our in vitro analyses of Atoh1iKO organoids demonstrate the opposite effect. That is, loss of Atoh1 in vitro leads to decreased tuft cell numbers. However, in contrast to Sox4cKO organoids, which fail to upregulate Dclk1 in response to exogenous IL13, Atoh1iKO organoids retain IL13-responsiveness in terms of Dclk1 expression. These data suggest that tuft cells may be specified by multiple signaling events and pathways, but that IL13-mediated tuft cell hyperplasia is Sox4-dependent and Atoh1-independent. In agreement, our gainof-function studies reveal that, although Atoh1iKO organoids exhibit reduced tuft cell numbers relative to non-recombined controls, Atoh1 is dispensable for Sox4-driven tuft cell differentiation.
A surprising result of our studies is the observation that Sox4 overexpression was sufficient to drive increased EEC differentiation in the absence of Atoh1. This effect does not appear to be the result of residual ATOH1 activity or non-specific Sox4 regulation of all secretory differentiation, as goblet cell-associated Muc2 expression remains severely downregulated in Atoh1iKO organoids at the timepoint examined, regardless of Sox4 expression status. These data raise interesting questions regarding the role of Atoh1 as a master regulator of secretory differentiation. To our knowledge, no other studies to date have expressed transcriptional regulators of secretory differentiation that are normally expressed upstream of Atoh1 in the absence of Atoh1. Further studies in this area would be necessary to determine if other transcription factors are capable of rescuing secretory differentiation in Atoh1iKO models.
The existence of Atoh1-independent lineage specification of tuft cells and EECs 
